Literature DB >> 3950248

Cardiac arrest in an adolescent with atrial fibrillation and hypertrophic cardiomyopathy.

W J Stafford, R G Trohman, M Bilsker, L Zaman, A Castellanos, R J Myerburg.   

Abstract

A 15 year old youth, who presented with out-of-hospital cardiac arrest due to documented ventricular fibrillation, was found to have nonobstructive hypertrophic cardiomyopathy. Electrophysiologic study demonstrated inducible sustained atrial fibrillation with a rapid ventricular response. This rhythm, associated with hypotension and evidence of myocardial ischemia, spontaneously degenerated into ventricular fibrillation. No ventricular arrhythmias were inducible by programmed ventricular stimulation. Therapy with metoprolol and verapamil slowed the ventricular rate during atrial fibrillation and maintained hemodynamic stability, both during follow-up electrophysiologic study and during a subsequent spontaneous episode.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 3950248     DOI: 10.1016/s0735-1097(86)80484-3

Source DB:  PubMed          Journal:  J Am Coll Cardiol        ISSN: 0735-1097            Impact factor:   24.094


  18 in total

Review 1.  Chronic and paroxysmal atrial fibrillation: course, prognosis, and stroke risk.

Authors:  T E Cuddy
Journal:  J Thromb Thrombolysis       Date:  1999-01       Impact factor: 2.300

2.  Through the looking glass: reminiscence from a pediatrician-come-lately.

Authors:  Richard G Trohman
Journal:  Pediatr Cardiol       Date:  2008-08-14       Impact factor: 1.655

Review 3.  Risk-benefit assessment of amiodarone in the treatment of cardiac arrhythmias.

Authors:  P J Counihan; W J McKenna
Journal:  Drug Saf       Date:  1990 Jul-Aug       Impact factor: 5.606

4.  Hypertrophic Cardiomyopathy.

Authors:  Elijah R. Behr; William J. McKenna
Journal:  Curr Treat Options Cardiovasc Med       Date:  2002-12

5.  Risk for atrial fibrillation in patients with hypertrophic cardiomyopathy assessed by signal averaged P wave duration.

Authors:  F Cecchi; A Montereggi; I Olivotto; P Marconi; A Dolara; B J Maron
Journal:  Heart       Date:  1997-07       Impact factor: 5.994

6.  Risk factors and stratification for sudden cardiac death in patients with hypertrophic cardiomyopathy.

Authors:  B J Maron; F Cecchi; W J McKenna
Journal:  Br Heart J       Date:  1994-12

7.  Genome editing with CRISPR/Cas9 in postnatal mice corrects PRKAG2 cardiac syndrome.

Authors:  Chang Xie; Ya-Ping Zhang; Lu Song; Jie Luo; Wei Qi; Jialu Hu; Danbo Lu; Zhen Yang; Jian Zhang; Jian Xiao; Bin Zhou; Jiu-Lin Du; Naihe Jing; Yong Liu; Yan Wang; Bo-Liang Li; Bao-Liang Song; Yan Yan
Journal:  Cell Res       Date:  2016-08-30       Impact factor: 25.617

8.  Cardiac dysrhythmias in children with idiopathic dilated or hypertrophic cardiomyopathy.

Authors:  G Müller; H E Ulmer; K J Hagel; D Wolf
Journal:  Pediatr Cardiol       Date:  1995 Mar-Apr       Impact factor: 1.655

Review 9.  [Limits and scopes of invasive risk stratification. Do we still need programmed ventricular stimulation?].

Authors:  Sascha Rolf; Wilhelm Haverkamp
Journal:  Herz       Date:  2009-11       Impact factor: 1.443

10.  CMR findings in patients with hypertrophic cardiomyopathy and atrial fibrillation.

Authors:  Theano Papavassiliu; Tjeerd Germans; Stephan Flüchter; Christina Doesch; Anton Suriyakamar; Dariusch Haghi; Tim Süselbeck; Christian Wolpert; Dietmar Dinter; Stefan O Schoenberg; Albert C van Rossum; Martin Borggrefe
Journal:  J Cardiovasc Magn Reson       Date:  2009-09-09       Impact factor: 5.364

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.